logo
Select company
Select metric
$ 162KNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
40
Sector
71
Industry
83
History
95
$ 11.01Close
$ 4.26 - $ 15.16 52-Week Range
Ticker Information

Ticker

ENTA

Company Name

ENANTA PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ENANTA PHARMACEUTICALS INC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ENTA - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ 162K
3/31/2025$ 190K
12/31/2024$ 241K
9/30/2024$ 147K
6/30/2024$ 79K
3/31/2024$ 251K
12/31/2023$ 1.08M
9/30/2023$ 2.21M
6/30/2023$ 5.14M
3/31/2023$ 9.06M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ENANTA PHARMACEUTICALS INC's latest trailing twelve months (TTM) CF - Equity stands at $ 10.48M.
  • Over the past 5 years, ENANTA PHARMACEUTICALS INC's average CF - Equity has been $ 6.58M.
  • The median CF - Equity for ENANTA PHARMACEUTICALS INC during this period was $ 4.38M
  • ENANTA PHARMACEUTICALS INC reached its highest CF - Equity over the past 5 years at $ 21.26M.
  • The lowest CF - Equity recorded by ENANTA PHARMACEUTICALS INC in the same timeframe $ 79K

ENANTA PHARMACEUTICALS INC's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
THTX : THERATECHNOLOGIES INC -BDTX : BLACK DIAMOND THERAPEUTICS INC $ -45KPLX : PROTALIX BIOTHERAPEUTICS INC $ 12.81MALEC : ALECTOR INC $ 1.04MSGMO : SANGAMO THERAPEUTICS INC $ 46.61MCSBR : CHAMPIONS ONCOLOGY INC $ 344KSPRO : SPERO THERAPEUTICS INC $ 0CCCC : C4 THERAPEUTICS INC $ 10.16MTRDA : ENTRADA THERAPEUTICS INC $ 2.08MCELU : CELULARITY INC $ 3.53M

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

ENTA - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ 79K

Minimum

Jun 30, 2024

$ 21.26M

Maximum

Sep 30, 2022

$ 6.58M

Average

$ 4.38M

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 124.49K with a standard deviation of $ 17.66M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.9K
min$ -60.59M
max$ 60.64M
average$ 124.49K
median$ 0
std$ 17.66M